Wicha Lab in the news
Videos, podcasts and audio clips
Cancer stem cells: New frontier in cancer research. Taubman Institute Health Science Lecture Series. March 2013.
Curelauncher and meals to heal.Stupid Cancer Show: The voice of young adult cancer. BlogTalkRadio.com. 21 January 2013.
Stein, Rob. Lab findings support provocative theory on cancer 'enemy' within. All Things Considered, National Public Radio. 01 August 2012.
Cancer's Stem Cell Revolution: Introduction. March 2011.
Dr. Wicha's WJR (AM760) interview. 30 September 2010
News articles and press releases
Fawcett, N. U-M Cancer Center director to step down: Wicha to focus on his research after 27 years at the helm. University of Michigan Health System news release. 18 November 2013.
Liquid biopsy could improve cancer diagnosis and treatment. University of Michigan News Service. 30 September 2013.
Hartman, Z. AACR: Targeting luminal breast cancer stem cells with trastuzumab blocks metastatic growth in preclinial models. Cancer Network, Conference report. 9 April, 2013.
Pescovitz, O. U-M Comprehensive Cancer Center: It started with notes on a napkin. Medicine that Speaks, 16 September 2013.
Fawcett, N. U-M start-up OncoMed has initial public offering. University of Michigan Health System news release. 23 July 2013.
Sifferlin, A. Herceptin may benefit wider group of breast cancer patients. Time Health and Family. 27 February, 2013.
U-M study challenges notion of using Herceptin only for HER2-positive breast cancer. University of Michigan Health System Headlines. 27 February, 2013.
U-M Cancer Center gets $28.4 million grant from NCI. University of Michigan Health System Headlines. 31 October, 2012.
Erb, Robin. Michigan is 5th-fattest state in U.S., which bodes ill for health expenses. Detroit Free Press, 19 September 2012.
Taubman Scholar Max Wicha: Research suggests help for Herceptin-resistant breast cancer. A. Alfred Taubman Medical Research Institute eNews, 2012.
Biointerfaces Institute at NCRC futhers the collaborative research mission. University of Michigan Health System Headlines. 22 August, 2012.
New program to create transformational hub for cancer research at University of Michigan. University of Michigan Health System Headlines. 6 August, 2012.
Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment. University of Michigan Health System News Release, 19 July, 2012.
Translational oncology establishes presence at NCRC: Dr. Max Wicha and researchers move their labs. University of Michigan North Campus Research Complex MomentUM, June 2012.
Azvolinksi, A. Cancer stem cells: Getting to the root of cancer. Journal of the National Cancer Institute, 2012. 104(12).
Bruck, L. University of Michigan Comprehensive Cancer Center: Leading the way in targeted therapies cancer care. OncLive, 7 June 2012.
Fawcett, N. Avastin, Sutent increase breast cancer stem cells, UM study shows. University of Michigan Health System news release, 25 January 2012.
Schattner, E. & Latour, K. Unlocking the mystery of cancer stem cells. CureToday, 14 September 2011.
UM Medical School and Medimmune join forces to accelerate search for new therapies. University of Michigan Health System news release, 21 November 2011.
Hannahan, M. 'U' researchers identify molecule that causes rapid movemebnt of cancer cells. Michigan Daily, 5 October 2011.
Susan G Komen For the Cure grants more than $6 million to Michigan scientists for new and novel breast cancer research. Komen News, 26 September 2011.
Fawcett, N. U-M gets $3.5M grant to study breast cancer stem cells, racial disparities. University Record, Week of 26 September 2011.
Snider, P. Cancer Center makes new discoveries in cancer stem cells. Michigan Daily, 26 May 2011.
deParry, B. UM scientists are at the forefront of cancer stem cell research. AnnArbor.com, 6 May 2011.
deParry, B. Candid cancer: Victories are mounting in the 40-year war on cancer. AnnArbor.com, 18 March 2011.
deParry, B. Candid cancer: Progress has been erratic in the 40-year war on cancer. AnnArbor.com, 11 March 2011.
Warner, F. From a trailer to a multimillion-dollar research clinic. dbusiness. March-April 2011.
Blocking inflammation receptor kills breast cancer stem cells, study finds. UM Comprehensive Cancer Center press release, 5 January 2010.
Erickson, J & Fawcett, N. U-M clinical trial for breast cancer promising. University Record, 11 October 2010.
Fulmer T. Targeting chemokines in breast cancer. Science-Business eXchange 2010;3(4).
Henderson, T. Director of University of Michigan's Cancer Center says targeting stem cells is key to patient survival. Crain's Detroit Business, October 6, 2010
Jacobs, S. What happens when stem cells go awry? 'U.' prof wonders aloud. Michigan Daily, October 6, 2010.
Pobojewski, S. UM's Cancer Dream Team. Medicine at Michigan, 2009.